FDA.reportPublic FDA data

250 ML lidocaine hydrochloride 4 MG/ML Injection

RxCUI
1737742
RxNorm name
250 ML lidocaine hydrochloride 4 MG/ML Injection
Display name
Lidocaine (Injectable)
Full name
250 ML lidocaine hydrochloride 4 MG/ML Injection
Term type
SCD
Status
Active
Strength
4 mg/ml
Dose form
Injection 250 ml
Route
Injectable
Updated
2026-10-21 07:30:34

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032016
Active start
032016
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride4 MG / 1 MLlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injection1649574

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STR250 ML lidocaine hydrochloride 4 MG/ML Injection1NAMES
RxNorm Name250 ML lidocaine hydrochloride 4 MG/ML Injection1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID
3 linked values
3CODES
RxCUI17377421CODES
MMSL_CODEMTH_RXN_BD18021CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0264-9594-200264-9594Lidocaine Hydrochloride and Dextrose LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATEB. Braun Medical Inc.NDA019830
84549-594-2084549-594Lidocaine Hydrochloride and Dextrose LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATEProPharma DistributionNDA019830

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0198300264-9594Lidocaine Hydrochloride and Dextrose LIDOCAINE HYDROCHLORIDE ANHYDROUS and DEXTROSE MONOHYDRATENDAB. Braun Medical Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 5 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00264959420rxnav_ndcsyes
00338040902rxnav_ndcsyes
84549059420rxnav_ndcsyes
00338959030rxnav_historical
00409793132rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lidocaine Hydrochloride and DextroseLIDOCAINE HYDROCHLORIDEBaxter Healthcare Corporationf21512ea-c7c3-4766-b976-b2c0b5616bf02026-02-20Warnings, Adverse reactionsExact identifier
ndc11 (package): 00338040902
rxcui: 1737742
Lidocaine Hydrochloride and DextroseLIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATEProPharma Distribution48c0ee87-f722-1a71-e063-6394a90a72d12026-01-19Warnings, Adverse reactionsExact identifier
ndc (package): 84549-594-20
ndc (product): 84549-594
ndc11 (package): 84549059420
rxcui: 1737742
Lidocaine Hydrochloride and DextroseLIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATEB. Braun Medical Inc.7dff29d9-522d-40eb-a9d9-42377912d6402026-01-14Warnings, Adverse reactionsExact identifier
ndc (package): 0264-9594-20
ndc (product): 0264-9594
ndc11 (package): 00264959420
rxcui: 1737742

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7dff29d9-522d-40eb-a9d9-42377912d640lidocaine HCl 0.4 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 4 MG/ML Injection [SCD] · lidocaine HCl 0.4 % per 250 ML Injection [SY] · lidocaine HCl 1 GM per 250 ML Injection [SY]419Lidocaine Hydrochloride and 5% Dextrose Injection USP20260114
f21512ea-c7c3-4766-b976-b2c0b5616bf0lidocaine HCl 0.4 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 4 MG/ML Injection [SCD] · lidocaine HCl 0.4 % per 250 ML Injection [SY] · lidocaine HCl 1 GM per 250 ML Injection [SY]417Lidocaine Hydrochloride and 5% Dextrose Injection, USP in Plastic Container Viaflex Plus Container20260220
48c0ee87-f722-1a71-e063-6394a90a72d1lidocaine HCl 0.4 % in 250 ML Injection [PSN] · 250 ML lidocaine hydrochloride 4 MG/ML Injection [SCD] · lidocaine HCl 0.4 % per 250 ML Injection [SY] · lidocaine HCl 1 GM per 250 ML Injection [SY]41Lidocaine Hydrochloride and 5% Dextrose Injection USP20260119

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f21512ea-c7c3-4766-b976-b2c0b5616bf0Lidocaine Hydrochloride and 5% Dextrose Injection, USP in Plastic Container Viaflex Plus ContainerBaxter Healthcare Corporation20260220
48c0ee87-f722-1a71-e063-6394a90a72d1Lidocaine Hydrochloride and 5% Dextrose Injection USPProPharma Distribution20260119
7dff29d9-522d-40eb-a9d9-42377912d640Lidocaine Hydrochloride and 5% Dextrose Injection USPB. Braun Medical Inc.20260114
a6cdf127-efff-4f0e-9334-e344e4c7a0a9National Council for Prescription Drug Programs20120724
e25a6343-ade0-4899-b90d-a6121d149965National Council for Prescription Drug Programs20120724
efb81e3e-58f8-44f6-9f96-cc072ab1bcebNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH4 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY250 ML
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA018461
CODESNDANDA019830
CODESVUID4005950
NAMESPrescribable Synonymlidocaine HCl 0.4 % in 250 ML Injection
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File